United States · FDA National Drug Code directory
Tasigna
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0951_fe0fef5b-4f09-4f67-946f-67e84d10e102
- Product NDC
- 0078-0951
- Form
- CAPSULE
- Composition / generic term
- nilotinib
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20071029
- Source listing expiry
- 20261231
Source-listed ingredients
- NILOTINIB HYDROCHLORIDE MONOHYDRATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE in 1 BOTTLE, PLASTIC (0078-0951-66) · 0078-0951-66
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →